NU553 Midterm Study Guide

Success on the NU553 Midterm Exam requires more than memorizing medications. Students should understand how to prescribe safely, interpret pharmacologic principles, apply evidence-based treatment guidelines, and individualize therapy based on patient characteristics. This study guide summarizes the most commonly tested concepts in an organized, easy-to-read format to help advanced practice nursing students prepare for exams and strengthen their clinical decision-making skills. It covers safe prescribing, pharmacokinetics, antimicrobial therapy, psychiatric pharmacology, pain management, and other essential topics that support high-quality patient care in primary and advanced practice settings.

Week 1: Safe Prescribing and Clinical Pharmacology

Safe prescribing begins with making an accurate diagnosis. Before selecting a medication, healthcare providers must identify the underlying disease process and evaluate patient-specific factors such as age, weight, pregnancy status, renal and hepatic function, allergies, genetic variations, and current medications. Applying evidence-based prescribing principles helps improve therapeutic outcomes while reducing medication-related complications.

Principles of Safe Prescribing

Every prescription should be based on an accurate clinical assessment and include all legally required prescription components. Medication selection should always balance effectiveness with patient safety.

Important prescribing principles include:

• Establish an accurate diagnosis before initiating medication therapy.

• Write complete prescriptions with all required legal elements.

• Encourage patients to use community drug take-back programs for safe disposal of unused medications.

• Remember that Schedule II controlled substances cannot be refilled and require a new prescription each time.

• Calculate pediatric medication doses using body weight in kilograms (kg) to minimize dosing errors.

• During breastfeeding, medications with shorter half-lives are generally preferred because they reduce infant exposure.

• During pregnancy, carefully avoid medications with known teratogenic effects, especially during early fetal organ development.

Following these practices promotes medication safety and supports responsible prescribing across all patient populations.

NU553 Midterm Key Points: Pharmacokinetics and Drug Distribution

Understanding pharmacokinetics is essential because it explains how medications move through the body. Drug absorption, distribution, metabolism, and elimination directly influence therapeutic effectiveness and adverse effects.

Key pharmacokinetic concepts include:

• Intravenous (IV) medications have 100% bioavailability because they enter the bloodstream directly.

• Older adults often experience changes in body composition that alter the volume of distribution.

• Conditions such as edema and poor circulation can also affect medication distribution.

• Drugs competing for the same plasma protein-binding sites may increase free drug concentrations, raising the risk of toxicity.

• Agonist medications bind to receptors and activate a physiologic response, producing their intended therapeutic effects.

A strong understanding of these principles helps clinicians select appropriate medications and adjust dosages safely.

Pharmacogenomics and Individualized Drug Therapy

Pharmacogenomics examines how inherited genetic differences influence medication response. Incorporating genetic information into prescribing decisions allows clinicians to personalize treatment and improve patient safety.

Examples include:

• Genetic variations in CYP2C9 can reduce warfarin metabolism, increasing bleeding risk.

• Patients whose INR remains unstable despite good adherence may benefit from pharmacogenomic testing.

• Individualized medication therapy based on genetic testing can improve treatment effectiveness while reducing adverse drug reactions.

As precision medicine continues to evolve, pharmacogenomics is becoming an increasingly important component of advanced nursing practice.

Antimicrobial Therapy

Appropriate antibiotic prescribing is essential for reducing antimicrobial resistance and improving patient outcomes. Whenever possible, antibiotic therapy should be guided by culture and sensitivity results.

Evidence-based antimicrobial practices include:

• Obtain culture and sensitivity testing before initiating antibiotics whenever clinically appropriate.

• Modify therapy if resistance is identified.

• Use oral vancomycin for Clostridioides difficile infection because it acts locally within the gastrointestinal tract.

• Supplement patients receiving tuberculosis therapy with pyridoxine (vitamin B6) to help prevent peripheral neuropathy.

• Educate patients taking tetracycline antibiotics about the increased risk of photosensitivity and the importance of sun protection.

• Advise patients taking zidovudine that mild gastrointestinal upset may improve when the medication is taken with a small amount of food.

Appropriate antimicrobial stewardship protects both individual patients and public health.

Polypharmacy and Medication Safety

Polypharmacy is a significant concern, particularly among older adults with multiple chronic conditions. Taking numerous medications increases the risk of adverse drug reactions, drug interactions, medication errors, and poor adherence.

Common contributors to polypharmacy include:

• Multiple healthcare providers prescribing medications

• Several chronic medical conditions

• Prescribing additional medications to treat adverse effects caused by other drugs

• Medication stockpiling or duplication

Healthcare providers should regularly review medication lists and discontinue unnecessary medications whenever appropriate.

Another important prescribing concept is therapeutic interchange, which involves substituting one medication with another therapeutically equivalent drug after provider approval, often due to formulary or insurance requirements.

Week 2: Psychiatric Pharmacology and Pain Management

Selecting psychiatric medications requires careful evaluation of the patient’s symptoms, age, coexisting medical conditions, medication history, adverse effect profile, and personal preferences. Evidence-based prescribing improves symptom control while minimizing unwanted side effects.

Antidepressant Selection

Selective serotonin reuptake inhibitors (SSRIs) remain first-line therapy for many depressive and anxiety disorders, although medication selection should always be individualized.

Common Antidepressants and Their Clinical Uses

Selecting the most appropriate antidepressant requires balancing effectiveness with the patient’s medical history and potential adverse effects.

Important Psychiatric Prescribing Considerations

Healthcare providers should recognize several high-yield prescribing principles commonly tested on the NU553 Midterm.

Important clinical considerations include:

• Fluoxetine is considered a first-line SSRI for school-aged children with depression.

• SSRIs remain the preferred first-line treatment for most depressive disorders.

• Duloxetine may precipitate manic episodes in patients with bipolar disorder.

• St. John’s Wort interacts with anticoagulants and numerous prescription medications.

• Nursing home residents have an increased risk of depression and require regular mental health assessment.

Careful medication selection and patient monitoring improve both treatment adherence and clinical outcomes.

ADHD and Neurologic Disorders

Management of ADHD and selected neurologic disorders should be based on current clinical guidelines and individualized patient assessment.

Important treatment recommendations include:

• Methylphenidate remains a first-line treatment for school-aged children with ADHD.

• Bupropion may improve ADHD symptoms in selected adult patients.

• Risk factors for ADHD include parental smoking, low birth weight, and family history.

• Pramipexole is commonly recommended as first-line therapy for restless legs syndrome.

Early diagnosis and appropriate pharmacologic treatment can significantly improve quality of life and daily functioning.

Pain Management

Effective pain management begins by identifying the underlying pain mechanism. Treatment should always match the type and severity of pain while considering patient-specific risks and comorbidities.

Examples of evidence-based pain management include:

• Acetaminophen is appropriate for mild pain.

• Duloxetine effectively treats neuropathic pain associated with chronic low back pain.

• Gout produces nociceptive pain resulting from inflammation.

• Chronic opioid therapy commonly causes constipation, making preventive bowel management important.

• Methadone carries an increased risk of respiratory depression during medication-assisted treatment.

• Management of opioid use disorder should include evaluation of previous treatments, psychiatric comorbidities, and available social support.

• Patients with hypertension, congestive heart failure, chronic kidney disease, or peptic ulcer disease require careful assessment before prescribing NSAIDs.

Safe pain management requires balancing symptom relief with strategies that reduce medication-related harm.

 Week 3: Dermatology and Infectious Diseases

Dermatologic and infectious diseases are common conditions encountered in primary care and advanced nursing practice. Accurate assessment of skin lesions, prompt diagnosis, and evidence-based medication selection help prevent complications and improve patient outcomes. Advanced practice nurses should also recognize medication-specific precautions, patient education needs, and infection prevention strategies.

Common Skin Disorders and Their Recommended Treatments

Many skin conditions have characteristic clinical features that guide diagnosis and treatment. Selecting the appropriate therapy depends on identifying the underlying cause, symptom severity, and patient-specific considerations.

Older adults often present differently than younger patients. For example, contact dermatitis may appear with dry scaling instead of obvious redness (erythema), making careful assessment especially important.

Acne Pharmacology

Acne management should be individualized according to disease severity and previous treatment response. Patients with severe or treatment-resistant acne may require systemic medications.

Important prescribing considerations include:

• Isotretinoin is reserved for severe acne that has not responded to other therapies.

• Because isotretinoin is highly teratogenic, patients must participate in the iPLEDGE Risk Evaluation and Mitigation Strategy (REMS) program before receiving treatment.

• Women of childbearing potential require pregnancy testing and reliable contraception throughout therapy.

• Tretinoin commonly causes skin irritation during the first few weeks of treatment.

• If irritation becomes excessive, reducing application to every other night often improves tolerability while maintaining treatment effectiveness.

Patient education regarding sun protection, skin moisturization, and medication adherence plays an essential role in successful acne management.

Eye and Ear Infections

Eye and ear infections are frequently encountered in primary care. Appropriate antibiotic selection depends on the causative organism, patient age, allergy history, and infection severity.

Evidence-based treatment recommendations include:

• Erythromycin ophthalmic ointment is commonly prescribed for bacterial conjunctivitis.

• Topical antibiotic ear drops are first-line therapy for otitis externa.

• Amoxicillin remains the preferred first-line antibiotic for uncomplicated acute otitis media.

• Cefdinir is an appropriate alternative for patients with a non-severe penicillin allergy.

Providers should educate patients about completing the entire antibiotic course even if symptoms improve early.

Immunomodulating Therapy

Biologic medications have transformed the treatment of autoimmune diseases but require careful screening before therapy begins because they suppress the immune system.

Before initiating biologic agents such as infliximab, clinicians should:

• Screen for latent tuberculosis (TB).

• Perform either a tuberculin skin test (TST) or an interferon-gamma release assay (IGRA).

• Evaluate patients for active infections.

• Monitor closely for opportunistic infections throughout treatment.

Patients should also receive appropriate vaccinations before beginning immunosuppressive therapy whenever possible.

Diabetic Foot Infection Prevention

Patients with diabetes have an increased risk of foot infections due to peripheral neuropathy, vascular disease, and impaired wound healing.

Preventive strategies include:

• Maintaining optimal glycemic control.

• Performing regular foot examinations.

• Wearing properly fitted footwear.

• Promptly treating skin injuries and ulcers.

• Educating patients on daily foot inspections.

Good diabetes management significantly reduces infection risk and lowers the likelihood of lower-extremity amputation.

Week 4: Allergy, Hematology, Infectious Disease, and Anticoagulation

Week 4 focuses on allergic disorders, hematologic conditions, HIV management, organ transplantation, and anticoagulation therapy. These topics emphasize safe prescribing practices and evidence-based medication management across diverse patient populations.

Allergy Disorders

The first step in managing allergic conditions is identifying and avoiding the offending allergen whenever possible. Pharmacologic therapy should be tailored to symptom severity and patient characteristics.

Important clinical considerations include:

• Anaphylaxis is a Type I hypersensitivity reaction requiring immediate emergency treatment.

• Cetirizine 2.5 mg is an appropriate dose for many four-year-old children with allergic symptoms.

• Pseudoephedrine should never be combined with monoamine oxidase inhibitors (MAOIs) because the combination can cause severe hypertension.

• When intranasal corticosteroids fail to adequately control allergic rhinitis, oral fexofenadine may be considered.

Patient education regarding allergen avoidance remains an important component of long-term allergy management.

Hematologic Disorders

Correctly identifying the cause of anemia allows clinicians to provide targeted treatment rather than simply addressing symptoms.

Important prescribing concepts include:

• Cyanocobalamin (Vitamin B12) is the treatment of choice for pernicious anemia.

• Folate deficiency during pregnancy significantly increases the risk of neural tube defects.

• Iron deficiency anemia requires iron replacement therapy rather than routine multivitamin supplementation.

• Laboratory monitoring helps evaluate treatment response and guides ongoing management.

Appropriate diagnosis ensures patients receive the most effective therapy while preventing unnecessary medication use.

HIV and Hepatitis Management

Current HIV treatment emphasizes prevention, early diagnosis, and lifelong adherence to antiretroviral therapy.

Key prescribing principles include:

• Sexual transmission remains the most common route of HIV infection worldwide.

• Pre-exposure prophylaxis (PrEP) must be taken consistently every day to achieve maximum protection against HIV infection.

• Protease inhibitors may cause lipodystrophy and metabolic complications that require ongoing monitoring.

• Patient education regarding medication adherence is essential for viral suppression and prevention of drug resistance.

Early identification and consistent treatment improve long-term health outcomes and reduce HIV transmission.

Organ Transplantation

Successful organ transplantation depends on careful donor-recipient matching and lifelong immunosuppressive therapy.

Important clinical considerations include:

• Human leukocyte antigen (HLA) compatibility plays a major role in reducing rejection risk.

• Cyclosporine commonly causes gingival hyperplasia, resulting in swollen, enlarged, or bleeding gums.

• Regular dental care and excellent oral hygiene help reduce oral complications associated with immunosuppressive therapy.

• Lifelong medication adherence is necessary to prevent organ rejection.

Advanced practice nurses play a key role in monitoring medication safety and reinforcing adherence following transplantation.

Evidence-Based Anticoagulation Management

Anticoagulant medications reduce the risk of thromboembolic events but require careful monitoring to prevent bleeding complications.

Important evidence-based principles include:

• Warfarin therapy requires routine International Normalized Ratio (INR) monitoring.

• Elevated INR values often require temporarily withholding warfarin and reassessing the patient’s bleeding risk.

• A low D-dimer level helps exclude venous thromboembolism in patients with a low pretest probability.

• The Pulmonary Embolism Rule-out Criteria (PERC) assists clinicians in determining whether additional testing is necessary.

• Direct oral anticoagulants (DOACs) should not be used in patients with mechanical heart valves because of increased thromboembolic risk.

Regular laboratory monitoring and patient education significantly improve anticoagulation safety.

Clinical Pearls for Weeks 3–4

The following concepts are frequently tested on the NU553 Midterm examination:

• Hydrocortisone is commonly used for mild inflammatory skin disorders.

• Patients receiving isotretinoin must enroll in the iPLEDGE program.

• Oral doxycycline is an effective treatment for rosacea that does not respond to topical therapy.

• Screen for latent tuberculosis before prescribing biologic medications.

• Anaphylaxis represents a Type I hypersensitivity reaction.

• Cyanocobalamin treats pernicious anemia.

• Daily adherence is essential for HIV PrEP effectiveness.

• HLA compatibility reduces transplant rejection risk.

• Warfarin therapy requires routine INR monitoring.

• DOACs are contraindicated in patients with mechanical heart valves.

Week 5: Respiratory Disorders

Respiratory disorders are among the most frequently encountered conditions in primary care. Successful management depends on accurate diagnosis, appropriate antimicrobial selection, evidence-based treatment guidelines, and patient education. Advanced practice nurses should understand current recommendations for upper respiratory infections, pneumonia, asthma, chronic obstructive pulmonary disease (COPD), and medication safety.

Upper and Lower Respiratory Infections

Most respiratory infections are viral and do not require antibiotics. However, bacterial infections should be treated according to current clinical guidelines and patient-specific risk factors.

Key prescribing recommendations include:

• Amoxicillin-clavulanate (Augmentin) is the first-line treatment for acute bacterial sinusitis in most adults.

• Community-acquired pneumonia (CAP) commonly presents with:

  • Persistent cough

  • Fever

  • Tachycardia

  • Dyspnea

  • Chest X-ray infiltrates

• Patients with significant comorbidities may require broader antimicrobial coverage because they have a higher risk of drug-resistant organisms.

• Antibiotic selection should always consider allergy history, local resistance patterns, and severity of illness.

Prompt diagnosis and guideline-directed therapy reduce complications and improve recovery.

Asthma Management

Current asthma guidelines focus on controlling chronic airway inflammation, preventing exacerbations, and minimizing rescue inhaler use. Long-term management should be individualized according to asthma severity and symptom frequency.

Important asthma medications include:

• Inhaled corticosteroids (ICS) remain the cornerstone of long-term asthma control because they reduce airway inflammation.

• Budesonide-formoterol is the preferred as-needed therapy for many patients with mild asthma under current guidelines.

• Montelukast blocks leukotriene D4 receptors, reducing inflammation and bronchoconstriction.

• Prednisone is commonly prescribed as a short-course (“burst”) therapy during acute asthma exacerbations.

Patients should also receive education regarding inhaler technique, trigger avoidance, and adherence to controller medications.

COPD Management

COPD treatment focuses on slowing disease progression, relieving symptoms, preventing exacerbations, and improving quality of life.

Evidence-based management includes:

• Smoking cessation remains the most effective intervention to slow disease progression.

• Bronchodilators are the primary maintenance therapy for most patients.

• Annual influenza vaccination is recommended unless contraindicated.

• Pneumococcal vaccination should follow current CDC recommendations.

• Symptom severity and exacerbation history guide treatment escalation using GOLD guidelines.

Pulmonary rehabilitation and lifestyle modifications further improve functional outcomes.

Medication Safety in Respiratory Care

Safe prescribing requires understanding important medication warnings and potential adverse effects.

High-yield medication safety reminders include:

• Fluoroquinolones carry an FDA boxed warning for tendon rupture and tendon injury.

• Oseltamivir is most effective when started within 48 hours of influenza symptom onset.

• Azithromycin may prolong the QT interval, increasing the risk of cardiac arrhythmias in susceptible patients.

• Over-the-counter intranasal epinephrine products may elevate blood pressure and should be used cautiously in patients with cardiovascular disease.

Patient counseling helps improve medication adherence while minimizing preventable adverse effects.

Week 6: Cardiovascular Pharmacology

Cardiovascular disorders remain one of the leading causes of morbidity and mortality worldwide. Effective management requires evidence-based medication selection, routine monitoring, and individualized treatment based on comorbidities and contraindications.

Hypertension Management

Hypertension treatment should follow current evidence-based guidelines while considering patient age, race, pregnancy status, kidney function, and cardiovascular risk.

Common Antihypertensive Medications

Additional high-yield prescribing considerations include:

• ACE inhibitors and ARBs are contraindicated in patients with bilateral renal artery stenosis.

• Lifestyle modifications—including weight reduction, sodium restriction, regular exercise, smoking cessation, and moderation of alcohol intake—should accompany pharmacologic therapy.

Hypertension During Pregnancy

Medication selection during pregnancy requires balancing maternal blood pressure control with fetal safety.

Preferred antihypertensive medications include:

• Labetalol

• Hydralazine

• Methyldopa

ACE inhibitors and ARBs should be avoided throughout pregnancy because they can cause fetal kidney injury and congenital abnormalities.

Heart Failure Management

Evidence-based heart failure treatment improves survival, decreases hospitalizations, and enhances quality of life.

Important prescribing concepts include:

• ACE inhibitors reduce both morbidity and mortality in patients with heart failure.

• Digoxin may be added for selected patients with heart failure with reduced ejection fraction (HFrEF) who remain symptomatic despite optimized therapy.

• Spironolactone should not be prescribed in patients with hyperkalemia because it may further increase potassium levels.

• Regular monitoring of renal function and electrolytes is essential during treatment.

Patient education regarding sodium restriction, fluid management, and daily weight monitoring also supports successful long-term management.

Lipid Management

Statins remain the first-line medications for lowering LDL cholesterol and reducing cardiovascular risk.

Key concepts include:

• Statins inhibit HMG-CoA reductase, the rate-limiting enzyme in cholesterol synthesis.

• Atorvastatin may reduce LDL cholesterol by approximately 60%, depending on the prescribed dose.

• Liver function should be monitored according to current recommendations during statin therapy.

• High-density lipoprotein (HDL) helps transport excess cholesterol back to the liver for elimination through reverse cholesterol transport.

Combining medication therapy with lifestyle modification provides the greatest cardiovascular benefit.

Cardiovascular Emergencies

Rapid recognition and appropriate intervention improve outcomes in cardiovascular emergencies.

Important clinical considerations include:

• Obtain a 12-lead electrocardiogram (ECG) immediately for patients presenting with chest pain.

• Patients receiving warfarin who present with symptoms of acute stroke require INR assessment before thrombolytic therapy is considered.

• Severe anemia increases the risk of heart failure because of reduced oxygen delivery.

• Cardiac arrhythmias may occur more frequently in patients with:

  • Heart failure

  • Cocaine use

  • Alcohol misuse

  • Certain medications that prolong the QT interval

Prompt evaluation and evidence-based treatment reduce morbidity and mortality.

Stable Supraventricular Tachycardia (SVT)

Patients with stable SVT should initially receive non-pharmacologic vagal maneuvers before medication therapy is considered.

Effective vagal maneuvers include:

• Forceful coughing

• Breath-holding (Valsalva maneuver)

• Applying ice to the face

• Stimulating the gag reflex

These techniques increase vagal tone and may successfully terminate the arrhythmia without medication.

Evidence-Based Clinical Decision-Making

One of the most important responsibilities of advanced practice nurses is integrating current clinical evidence into patient care. Evidence-based prescribing improves treatment effectiveness while reducing medication-related complications.

Core principles include:

• Use current clinical practice guidelines whenever available.

• Schedule regular follow-up visits to evaluate medication effectiveness and adverse effects.

• Monitor laboratory values when required for medication safety.

• Encourage lifestyle modifications alongside pharmacologic treatment.

• Individualize therapy based on:

  • Age

  • Pregnancy status

  • Kidney and liver function

  • Genetics

  • Comorbidities

  • Patient preferences

  • Potential drug interactions

Patient-centered, evidence-based care remains the foundation of safe advanced nursing practice.

High-Yield Clinical Pearls for Weeks 5–6

The following concepts are commonly tested on the NU553 Midterm examination:

• Augmentin is first-line therapy for acute bacterial sinusitis.

• Inhaled corticosteroids remain the preferred long-term controller therapy for asthma.

• Budesonide-formoterol is recommended as needed for many patients with mild asthma.

• Smoking cessation is the most effective intervention for slowing COPD progression.

• Fluoroquinolones carry a boxed warning for tendon rupture.

• ACE inhibitors improve survival in heart failure.

• Labetalol, hydralazine, and methyldopa are preferred antihypertensives during pregnancy.

• Statins inhibit HMG-CoA reductase.

• Obtain an ECG immediately for patients with chest pain.

• Stable SVT should initially be treated with vagal maneuvers.

Summary

• Safe prescribing begins with an accurate diagnosis and individualized medication selection.

• Inhaled corticosteroids are the foundation of long-term asthma management.

• Smoking cessation is the most effective intervention for slowing COPD progression.

• ACE inhibitors improve survival in patients with heart failure but are contraindicated during pregnancy.

• Statins remain first-line therapy for reducing LDL cholesterol and cardiovascular risk.

• Evidence-based guidelines, laboratory monitoring, and patient education improve medication safety and clinical outcomes.

The following frequently asked questions address some of the highest-yield topics tested on the NU553 Midterm Exam. These concise, evidence-based answers are optimized for both student learning and AI-powered search platforms such as Google AI Overview, ChatGPT, Gemini, and Perplexity.

Frequently Asked Questions

What is the first step in safe prescribing?

The first step in safe prescribing is establishing an accurate diagnosis. Healthcare providers should identify the underlying disease process before selecting a medication and consider patient-specific factors such as age, allergies, pregnancy status, kidney and liver function, genetic variations, and current medications. Accurate diagnosis reduces prescribing errors and improves patient outcomes.

Why is pharmacokinetics important in prescribing medications?

Pharmacokinetics explains how medications are absorbed, distributed, metabolized, and eliminated by the body. Understanding these processes helps clinicians determine the appropriate drug, dose, route of administration, and dosing interval while minimizing adverse drug reactions.

Why should antibiotics be prescribed based on culture and sensitivity testing?

Culture and sensitivity testing identifies the causative organism and determines which antibiotics are most effective. This approach promotes targeted therapy, reduces unnecessary antibiotic use, limits antimicrobial resistance, and improves treatment success whenever testing is clinically feasible.

Which antidepressant is commonly recommended for children with depression?

Fluoxetine is one of the most evidence-supported selective serotonin reuptake inhibitors (SSRIs) for treating depression in school-aged children and adolescents. It is commonly considered a first-line pharmacologic option when medication therapy is indicated.

What medication is commonly used for ADHD in school-aged children?

Methylphenidate is considered a first-line medication for attention-deficit/hyperactivity disorder (ADHD) in school-aged children. Treatment should be combined with behavioral interventions and regular monitoring of growth, appetite, sleep, and symptom improvement.

Why is isotretinoin closely monitored?

Isotretinoin has significant teratogenic effects and may cause severe birth defects if taken during pregnancy. Because of this risk, patients must participate in the iPLEDGE Risk Evaluation and Mitigation Strategy (REMS) program and follow strict pregnancy prevention requirements throughout treatment.

What is the first-line treatment for acute bacterial sinusitis?

Current clinical guidelines recommend amoxicillin-clavulanate (Augmentin) as the preferred first-line antibiotic for most adults with acute bacterial sinusitis.

What is the cornerstone of long-term asthma management?

Inhaled corticosteroids (ICS) are the cornerstone of long-term asthma management because they reduce chronic airway inflammation, decrease exacerbations, improve lung function, and reduce the need for rescue inhalers.

Which antihypertensive medications are considered safe during pregnancy?

The antihypertensive medications most commonly recommended during pregnancy include:

• Labetalol

• Hydralazine

• Methyldopa

ACE inhibitors and angiotensin receptor blockers (ARBs) should be avoided because they may cause fetal kidney injury and congenital abnormalities.

Why are ACE inhibitors beneficial in heart failure?

ACE inhibitors reduce both morbidity and mortality in patients with heart failure. They decrease cardiac workload, improve ventricular remodeling, reduce hospitalizations, and improve long-term survival.

Why does warfarin require INR monitoring?

Warfarin has a narrow therapeutic index, meaning small dosage changes can significantly affect bleeding and clotting risk. Regular International Normalized Ratio (INR) monitoring ensures anticoagulation remains within the therapeutic range and helps guide dosage adjustments.

Why should direct oral anticoagulants (DOACs) not be used in patients with mechanical heart valves?

Current evidence demonstrates that DOACs are not as effective as warfarin for preventing thromboembolic complications in patients with mechanical heart valves. Therefore, warfarin remains the recommended anticoagulant for this patient population.

What is the most effective intervention for slowing COPD progression?

Smoking cessation is the single most effective intervention for slowing disease progression, improving lung function decline, and reducing COPD-related complications.

Why is pharmacogenomic testing becoming more important?

Pharmacogenomic testing helps identify inherited genetic differences that influence medication metabolism and response. Personalized prescribing based on genetic information can improve treatment effectiveness while reducing adverse drug reactions.

How can advanced practice nurses improve medication safety?

Advanced practice nurses improve medication safety by:

• Following evidence-based clinical guidelines.

• Reviewing medication interactions.

• Monitoring laboratory values.

• Individualizing therapy.

• Educating patients about medication adherence.

• Scheduling appropriate follow-up visits.

• Regularly evaluating treatment effectiveness and adverse effects.

Key Takeaways

The NU553 Midterm emphasizes the safe and evidence-based use of medications across diverse patient populations. Students should focus on developing clinical reasoning skills rather than memorizing drug names alone. Understanding pharmacologic mechanisms, disease-specific treatment guidelines, contraindications, adverse effects, and patient-specific considerations allows advanced practice nurses to provide high-quality, patient-centered care.

Major concepts to review include:

• Safe prescribing principles

• Pharmacokinetics and pharmacogenomics

• Antimicrobial stewardship

• Psychiatric pharmacology

• Pain management

• Dermatologic disorders

• Allergy and infectious disease management

• Anticoagulation therapy

• Respiratory disease treatment

• Cardiovascular pharmacology

• Guideline-directed medical therapy

• Medication safety across special populations, including children, pregnant patients, and older adults

Consistently applying current clinical practice guidelines, monitoring therapeutic response, and involving patients in shared decision-making are essential components of effective advanced nursing practice. Combining evidence-based prescribing with individualized care improves therapeutic outcomes, minimizes medication-related harm, and supports long-term patient health.

Summary

• Safe prescribing begins with an accurate diagnosis and individualized patient assessment.

• Pharmacokinetics and pharmacogenomics guide personalized medication therapy.

• Culture-guided antibiotic prescribing supports antimicrobial stewardship.

• Fluoxetine is a first-line SSRI for many children and adolescents with depression.

• Inhaled corticosteroids remain the foundation of long-term asthma control.

• Smoking cessation is the most effective intervention for slowing COPD progression.

• ACE inhibitors improve survival in heart failure but are contraindicated during pregnancy.

• Warfarin therapy requires regular INR monitoring.

• Statins remain first-line therapy for dyslipidemia and cardiovascular risk reduction.

• Evidence-based clinical guidelines improve medication safety and patient outcomes.

References

American Diabetes Association. (2025). Standards of care in diabetes—2025. Diabetes Care. https://diabetesjournals.org/care

Centers for Disease Control and Prevention. (2024). Antibiotic prescribing and use. https://www.cdc.gov/antibiotic-use/

Centers for Disease Control and Prevention. (2024). Adult immunization schedule. https://www.cdc.gov/vaccines/

Global Initiative for Asthma. (2025). Global strategy for asthma management and prevention. https://ginasthma.org/

Global Initiative for Chronic Obstructive Lung Disease. (2025). Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. https://goldcopd.org/

NU553 Midterm Key Points: Essential Prescribing Concepts and Drug Management

Lexicomp. (2025). Drug information handbook. Wolters Kluwer. https://www.wolterskluwer.com/en/solutions/lexicomp

Rosenthal, L. D., & Burchum, J. R. (2024). Lehne’s pharmacology for nursing care (12th ed.). Elsevier.

U.S. Preventive Services Task Force. (2024). Recommendation statements. https://www.uspreventiveservicestaskforce.org/

Woo, T. M., & Robinson, M. V. (2024). Pharmacotherapeutics for advanced practice nurse prescribers (6th ed.). F. A. Davis.